Migraine Treatment Drugs Market

Segmentation By Type (Chronic and Episodic); By Treatment Type (Abortive Treatment and Preventive Treatment); By Route of Administration Type (Injectable, Nasal Sprays, Oral and Others); By End Users (Hospitals, Online Pharmacies, Retail Pharmacies and Others) - Global Demand Analysis & Opportunity Outlook 2028

Buy Now
Report ID: 2752 | Published On: Feb 15, 2023
Request Free Sample Copy

Market Segmentation

Our in-depth analysis of migraine treatment drugs market includes the following segments:

By Type

  • Chronic Migraine
  • Episodic Migraine

By Treatment Type

  • Abortive Treatment 
    • Triptans
    • Ergot Alkaloids
    • Others
  • Preventive Treatment 
    • Topiramate
    • Botulinum Toxin
    • Others

By Route of Administration

  • Injectable
  • Nasal Sprays
  • Oral
  • Others

By End Users

  • Hospitals
  • Online Pharmacies
  • Retail Pharmacies
  • Others

By Region

On the basis of regional analysis, the migraine treatment drugs market is segmented into five major region including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market for migraine treatment drugs in North America is anticipated to dominate the market owing to its geography, increasing adoption of novel therapies and high prevalence of migraine. The Asia Pacific is projected to see significant growth in future on the account of rising demand for better healthcare services along with the contribution from the major developing economies such as India and China towards migraine treatment drugs. Moreover, large undeserved patient population and high penetration from drug manufacturers is adding up to the key factors driving the growth of the market in the region over the forecast period.

The migraine treatment drugs market is further classified on the basis of region as follows:

  • North America (US and Canada) Market size, Y-O-Y growth and Opportunity analysis.
  • Europe (France, Germany, Italy, Spain, UK, and Other parts of Europe) Market size, Y-O-Y growth and Opportunity analysis.
  • Asia Pacific (Japan, India, China, Australia and rest of Asia Pacific) Market size, Y-O-Y growth and Opportunity analysis.
  • Latin America (Mexico, Argentina and Brazil) Market size, Y-O-Y growth and Opportunity analysis.
  • Middle East & Africa (Middle East, South Arabia and South Africa) Market size, Y-O-Y growth and Opportunity analysis.

Get more information on this report: Request Sample PDF

Market Size and Forecast

The market for migraine treatment drugs is anticipated to record a CAGR of around 12% over the forecast period, 2020-2028. The major key factors projected to drive the growth of the market include rise in the prevalence of migraines, stressed lifestyle along with rising healthcare expenditure. Since, numbers of migraine incidences are increasing and order to meet the unmet demand in migraine drugs, most of the companies are investing in research and development areas pertaining to migraine treatment drugs. Further, novel product innovations and development of new devices for the new treatment options for migraine is anticipated to accelerate the growth of the market over the forecast period.

The treatment type is segmented into abortive treatment and preventive treatment. Based upon segmentation by treatment type, the market for abortive segment is anticipated to dominate the market on the account of ease of self administration for the people having vomiting or nausea related to migraine. In addition, abortive treatment works quickly when used at the first sign of migraine. These factors are forecasted to drive the growth of the market. CLICK TO DOWNLOAD SAMPLE REPORT

Growth Drivers

Increase in the Female Population

Migraines are more frequent in women as compared to men. This migraine in women’s is assigned to the rising and falling levels of estrogen during menstruation, menopause and pregnancy. Further, before puberty the prevalence of migraine in males and females remains same, however the first migraine in females occur when their periods begin and after puberty, it increases in females almost three times than males. Therefore, with the increase in the population of females, number of migraineurs is anticipated to increase, thus, driving the growth of the market.

Increase in Awareness regarding Migraine

The rising awareness related to migraine and the drugs available for its treatment is one of the major factors accelerating the growth of migraine treatment drugs market. A number of organisations, such as, American Headache Society, are taking measures to spread awareness related to migraine therapeutics and to provide support to the patients regarding the disorders related to headache. Moreover, financial burdens and bad environmental conditions are increasing the demand to cure stress and to aware people about mental health. Hence, awareness about migraine is estimated to drive the growth of market over the forecast period.


Different Side Effects from Migraine Treatment Drugs

Migraine treatment includes acute therapy and preventive therapy. Since, patients want to get faster or complete relief, without any adverse affects or drugs. However, frequent use of some medications can lead to the happening of disabling condition in the patients. The side effects of the medications depend on the specific drug. Taking multiple drugs together can cause excess of serotonin in the human body leading to life threatening conditions. Hence, side effects of the migraine treatment drugs are likely to hamper the market growth over the forecast period.

Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

In The News

  • On February 15, 2020, a new prescription medication Reyvow was approved by the Drug Enforcement Application (DEA) to provide treatment for acute migraines and associated symptoms such as nausea and sensitivity to light & sound. This medicine is especially for patients having disabling problems and who do not respond to medicines.

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample